This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter
Ben Fidler is a Senior Editor at BioPharma Dive. With over 15 years of experience as a business journalist, he specializes in the biotechnology sector, covering topics such as pharmaceutical manufacturing, gene therapy, and immunotherapy, while also exploring the intersection of AI and healthcare. Ben's work has been featured in prominent outlets including Lexology, PharmaVoice, and Yahoo Finance.